Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent.
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).
Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice.
TOX is expressed by exhausted and polyfunctional human effector memory CD8 + T cells
Correction to: Novel Approaches Towards a Functional Cure of HIV/AIDS.
Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya.
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80.
Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice.
HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design.